Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Spotlight On 3 Penny Stocks With Market Caps Over $60M

In This Article:

Recently, the major U.S. stock indexes have shown resilience, snapping a four-week losing streak with gains fueled by a rally in big tech stocks. Amidst this backdrop of cautious optimism and market volatility, penny stocks continue to capture attention as potential investment opportunities. Although the term "penny stock" may seem outdated, these smaller or newer companies can offer significant growth potential when supported by strong financials and solid fundamentals. In this article, we will highlight several noteworthy penny stocks that stand out for their financial strength and long-term promise.

Top 10 Penny Stocks In The United States

Name

Share Price

Market Cap

Financial Health Rating

Safe Bulkers (NYSE:SB)

$3.74

$392.12M

★★★★☆☆

Tuya (NYSE:TUYA)

$3.49

$2.08B

★★★★★★

Global Self Storage (NasdaqCM:SELF)

$5.00

$56.35M

★★★★★☆

Sensus Healthcare (NasdaqCM:SRTS)

$4.71

$77.69M

★★★★★★

Golden Growers Cooperative (OTCPK:GGRO.U)

$4.50

$67.38M

★★★★★★

TETRA Technologies (NYSE:TTI)

$3.35

$443.52M

★★★★☆☆

Imperial Petroleum (NasdaqCM:IMPP)

$2.55

$77.35M

★★★★★★

BAB (OTCPK:BABB)

$0.8499

$6.17M

★★★★★★

QuantaSing Group (NasdaqGM:QSG)

$3.08

$140.05M

★★★★★★

CBAK Energy Technology (NasdaqCM:CBAT)

$0.8203

$73.78M

★★★★★☆

Click here to see the full list of 761 stocks from our US Penny Stocks screener.

Here we highlight a subset of our preferred stocks from the screener.

Definitive Healthcare

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Definitive Healthcare Corp. offers a SaaS healthcare commercial intelligence platform operating both in the United States and internationally, with a market cap of approximately $428.10 million.

Operations: The company generates revenue from its Internet Information Providers segment, totaling $252.20 million.

Market Cap: $428.1M

Definitive Healthcare, with a market cap of US$428.10 million, is navigating challenges typical for penny stocks. Despite being unprofitable and reporting increased net losses of US$413.12 million in 2024, the company maintains a cash runway exceeding three years due to positive free cash flow. It trades significantly below estimated fair value and has avoided shareholder dilution recently. However, its share price remains highly volatile, and recent goodwill impairment charges of US$97.06 million highlight financial pressures. Leadership changes are underway with Casey Heller set to become CFO in June 2025 amidst ongoing strategic adjustments.